|
|
Volumn 37, Issue 1, 2011, Pages 90-92
|
|
Ganciclovir pharmacokinetics and suggested dosing in continuous venovenous haemodiafiltration
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
GANCICLOVIR;
MEROPENEM;
METHYLPREDNISOLONE;
PREDNISOLONE;
VIRUS DNA;
AGED;
AREA UNDER THE CURVE;
BRONCHOSCOPY;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
CONTINUOUS HEMODIAFILTRATION;
CRITICALLY ILL PATIENT;
CYTOMEGALOVIRUS INFECTION;
DOSE CALCULATION;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG DOSE REGIMEN;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG MEGADOSE;
DRUG MONITORING;
DRUG PULSE THERAPY;
DUODENAL ULCER BLEEDING;
ENTEROBACTERIACEAE INFECTION;
GENERAL CONDITION DETERIORATION;
GRAM NEGATIVE SEPSIS;
HOSPITAL INFECTION;
HUMAN;
HYPOXEMIA;
IMMUNE COMPLEX NEPHRITIS;
INTENSIVE CARE UNIT;
KIDNEY CLEARANCE;
KIDNEY INJURY;
LETTER;
LUNG HEMORRHAGE;
MALE;
MAXIMUM PLASMA CONCENTRATION;
PLASMAPHERESIS;
PNEUMONIA;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PSEUDOMONAS INFECTION;
THROMBOCYTOPENIA;
ULTRAFILTRATION;
AGED;
ANTIVIRAL AGENTS;
CRITICAL ILLNESS;
CYTOMEGALOVIRUS INFECTIONS;
GANCICLOVIR;
HEMOFILTRATION;
HUMANS;
MALE;
|
|
EID: 78650279229
PISSN: 09248579
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ijantimicag.2010.10.003 Document Type: Letter |
|
Times cited : (7)
|
|
References (5)
|
